These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 18349401

  • 1. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    Koopmans KP, Neels OC, Kema IP, Elsinga PH, Sluiter WJ, Vanghillewe K, Brouwers AH, Jager PL, de Vries EG.
    J Clin Oncol; 2008 Mar 20; 26(9):1489-95. PubMed ID: 18349401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.
    J Clin Endocrinol Metab; 2009 Oct 20; 94(10):3922-30. PubMed ID: 19622618
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
    Montravers F, Grahek D, Kerrou K, Ruszniewski P, de Beco V, Aide N, Gutman F, Grangé JD, Lotz JP, Talbot JN.
    J Nucl Med; 2006 Sep 20; 47(9):1455-62. PubMed ID: 16954553
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography.
    Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, Langstrom B, Bergstrom M, Eriksson B.
    J Clin Endocrinol Metab; 2005 Jun 20; 90(6):3392-400. PubMed ID: 15755858
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
    Kuyumcu S, Adalet I, Sanli Y, Turkmen C, Ozkan ZG, Yilmazbayhan D.
    Ann Nucl Med; 2012 Nov 20; 26(9):689-97. PubMed ID: 22802007
    [Abstract] [Full Text] [Related]

  • 11. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Kema IP, Koopmans KP, Valk GD, Timmers HJ, de Herder WW, Feelders RA, Fockens P, Sluiter WJ, de Vries EG, Links TP.
    Gastrointest Endosc; 2015 Jan 20; 81(1):159-167.e2. PubMed ID: 25527055
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.
    Orlefors H, Sundin A, Ahlström H, Bjurling P, Bergström M, Lilja A, Långström B, Oberg K, Eriksson B.
    J Clin Oncol; 1998 Jul 20; 16(7):2534-41. PubMed ID: 9667275
    [Abstract] [Full Text] [Related]

  • 15. Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography.
    Orlefors H, Sundin A, Lu L, Oberg K, Långström B, Eriksson B, Bergström M.
    Eur J Nucl Med Mol Imaging; 2006 Jan 20; 33(1):60-5. PubMed ID: 16184369
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functional imaging in hyperinsulinemic hypoglycemia after gastric bypass surgery for morbid obesity.
    de Heide LJ, Glaudemans AW, Oomen PH, Apers JA, Totté ER, van Beek AP.
    J Clin Endocrinol Metab; 2012 Jun 20; 97(6):E963-7. PubMed ID: 22466332
    [Abstract] [Full Text] [Related]

  • 18. Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.
    Binderup T, Knigge U, Loft A, Mortensen J, Pfeifer A, Federspiel B, Hansen CP, Højgaard L, Kjaer A.
    J Nucl Med; 2010 May 20; 51(5):704-12. PubMed ID: 20395333
    [Abstract] [Full Text] [Related]

  • 19. Nuclear imaging of neuroendocrine tumours.
    Sundin A, Garske U, Orlefors H.
    Best Pract Res Clin Endocrinol Metab; 2007 Mar 20; 21(1):69-85. PubMed ID: 17382266
    [Abstract] [Full Text] [Related]

  • 20. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
    Hoegerle S, Altehoefer C, Ghanem N, Brink I, Moser E, Nitzsche E.
    Eur J Nucl Med; 2001 Jan 20; 28(1):64-71. PubMed ID: 11202454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.